← Browse by Condition
Medical Condition

recurrent or metastatic nasopharyngeal carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06657690 Phase 2
Recruiting

Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Enrollment
56 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →